Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.7.49 (
reverse transcriptase
)
31,746
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The protein tyrosine phosphatases
PTP-SL
and
PTPBR7
differ only in the length of their N-terminal domain. We show here that
PTP-SL
and
PTPBR7
are isoforms derived from a single gene (Ptprr) through developmentally regulated use of alternative promoters. Isoform-specific
reverse transcriptase
-polymer chain reaction (RT-PCR) and RNA in situ hybridization experiments reveal that
PTPBR7
is expressed during early embryogenesis in spinal ganglia cells as well as in developing Purkinje cells. Post-natally,
PTPBR7
is expressed in various regions of the adult mouse brain, but expression in Purkinje cells has ceased and is replaced by the
PTP-SL
-specific transcript. In transient transfection experiments it is confirmed that
PTPBR7
is a type I transmembrane protein tyrosine phosphatase (PTPase).
PTP-SL
, however, appears to be a cytosolic membrane-associated PTPase that is located at perinuclear vesicular structures that partly belong to the endosomal compartment. Thus, during maturation of Purkinje cells, a gene-promoter switch results in the replacement of a receptor-type PTPase by a cytosolic vesicle-associated isoform.
...
PMID:The mouse Ptprr gene encodes two protein tyrosine phosphatases, PTP-SL and PTPBR7, that display distinct patterns of expression during neural development. 1058 72